Literature DB >> 9374572

Exudative lung injury is associated with decreased levels of surfactant proteins in a rat model of meconium aspiration.

G M Cleary1, M J Antunes, D A Ciesielka, S T Higgins, A R Spitzer, A Chander.   

Abstract

OBJECTIVE: Meconium aspiration syndrome remains a common cause of respiratory failure in neonates. The acute effects of meconium aspiration are inactivation of lung surfactant in vivo and in vitro. This study investigated the delayed effects of meconium on alveolar surfactant phospholipids and protein levels in spontaneously breathing animals.
METHODS: Twenty-two adult rats were given 4.3 mg of dry weight human meconium after endotracheal intubation. Rats were briefly mechanically ventilated in room air, extubated, then killed after 16 (n = 6), 24 (n = 6), 48 (n = 6), and 72 hours (n = 4). Control animals received the same volume of normal saline (n = 7) or no meconium (n = 7). Bronchoalveolar lavage and tissue specimens were evaluated for inflammatory cells, total proteins, surfactant phospholipids, and surfactant proteins.
RESULTS: Meconium caused exudative lung injury that was reflected in increased cell counts and proteins in alveolar lavage fluid. The peak injury occurred at 16 hours after instillation, whereas recovery occurred by 72 hours. Although total lavage fluid phospholipids did not change over time, phospholipid and dipalmitoyl phosphatidylcholine in large aggregates tended to decrease at 24 hours. Western blot analysis demonstrated time-dependent qualitative decreases in surfactant proteins A and B (SP-A, SP-B) in meconium-instilled animals compared with the controls. ELISA for SP-B confirmed the Western blot findings with total SP-B in large aggregate decreasing from 25 +/- 4 microg in controls to 6.6 +/- 0.8 microg at 24 hours of injury.
CONCLUSIONS: Our study suggests that the exudative lung injury with meconium instillation is associated with decreased levels of SP-A and SP-B in the large aggregate fraction of lung surfactant. We speculate that decreased secretion and/or increased degradation accounts for lower levels of SP-B in bronchoalveolar lavage fluid.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374572     DOI: 10.1542/peds.100.6.998

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

1.  A randomised control study of partial liquid ventilation after airway lavage with exogenous surfactant in a meconium aspiration syndrome animal model.

Authors:  T Nakamura; S Matsuzawa; M Sugiura; M Tamura
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

Review 2.  Surfactant therapy for meconium aspiration syndrome: current status.

Authors:  Peter A Dargaville; John F Mills
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease.

Authors:  Tara Sudhadevi; Alison W Ha; Anantha Harijith
Journal:  J Vis Exp       Date:  2021-08-04       Impact factor: 1.424

Review 4.  Glucocorticoids in the treatment of neonatal meconium aspiration syndrome.

Authors:  Daniela Mokra; Juraj Mokry
Journal:  Eur J Pediatr       Date:  2011-04-06       Impact factor: 3.183

5.  Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran.

Authors:  Matthias Ochs; Markus Schüttler; Guido Stichtenoth; Egbert Herting
Journal:  Respir Res       Date:  2006-06-06

6.  Saline lavage with substitution of bovine surfactant in term neonates with meconium aspiration syndrome (MAS) transferred for extracorporeal membrane oxygenation (ECMO): a pilot study.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

Review 7.  Exogenous surfactant therapy in 2013: what is next? Who, when and how should we treat newborn infants in the future?

Authors:  Emmanuel Lopez; Géraldine Gascoin; Cyril Flamant; Mona Merhi; Pierre Tourneux; Olivier Baud
Journal:  BMC Pediatr       Date:  2013-10-10       Impact factor: 2.125

Review 8.  Surfactant therapy and antibiotics in neonates with meconium aspiration syndrome: a systematic review and meta-analysis.

Authors:  C K Natarajan; M J Sankar; K Jain; R Agarwal; V K Paul
Journal:  J Perinatol       Date:  2016-05       Impact factor: 2.521

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.